LTFS
BLCM

Ladenburg Thalmann Financial Services’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$7K Sell
590
-46
-7% -$425 ﹤0.01% 4664
2019
Q3 		$6K Buy
636
+475
+295% +$6.21K ﹤0.01% 4640
2019
Q2 		$4K Hold
161
– – ﹤0.01% 4818
2019
Q1 		$5K Hold
161
– – ﹤0.01% 4693
2018
Q4 		$5K Hold
161
– – ﹤0.01% 4627
2018
Q3 		$11K Buy
161
+100
+164% +$6.77K ﹤0.01% 4255
2018
Q2 		$5K Hold
61
– – ﹤0.01% 4612
2018
Q1 		$5K Buy
61
+10
+20% +$755 ﹤0.01% 4612
2017
Q4 		$4K Sell
51
-9
-15% -$883 ﹤0.01% 4622
2017
Q3 		$7K Buy
60
+10
+20% +$1.05K ﹤0.01% 4278
2017
Q2 		$6K Hold
50
– – ﹤0.01% 4279
2017
Q1 		$6K Sell
50
-5
-9% -$655 ﹤0.01% 4256
2016
Q4 		$9K Hold
55
– – ﹤0.01% 3971
2016
Q3 		$11K Buy
55
+14
+34% +$2.41K ﹤0.01% 3776
2016
Q2 		$5K Hold
41
– – ﹤0.01% 4154
2016
Q1 		$4K Buy
+41
New +$4.46K ﹤0.01% 4194

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BLCM Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Bellicum Pharmaceuticals, Inc. (BLCM) stake by 7.2% in Q4 2019, selling an estimated $425 and leaving 590 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4664.

Ladenburg Thalmann Financial Services first reported a position in BLCM in Q1 2016 and has held it in 16 quarters since. The position peaked at $11K in Q3 2018. 51 funds tracked by Wall St. Rank hold BLCM as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 590 shares of Bellicum Pharmaceuticals, Inc. worth $7K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 46 Bellicum Pharmaceuticals, Inc. shares in Q4 2019, an estimated $425.
  • Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4664 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2016 and has held it in 16 quarters since.
  • Ladenburg Thalmann Financial Services's Bellicum Pharmaceuticals, Inc. position peaked at $11K in Q3 2018.
  • 51 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.